13F Filings History of ACUTA CAPITAL PARTNERS, LLC

Latest 13F report
Q3 2025 - 14 Nov 2025
Value $
$96,768,753
Signature - Title
Scott Smith - Chief Operating Officer
Location
Redwood City, CA
Summary
This page shows a list of all the recent 13F filings made by ACUTA CAPITAL PARTNERS, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. ACUTA CAPITAL PARTNERS, LLC reported 28 stock holdings with total value $96,768,753 as of Q3 2025. Top holdings included OCUL, CDTX, TRML, WHWK, and INSM.

Notify me when ACUTA CAPITAL PARTNERS, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 28 $96,768,753 +$18,369,713 -$24,314,427 -$5,944,714 OCUL, CDTX, TRML, WHWK, INSM 13F-HR 14 Nov 2025, 15:08
Q2 2025 28 $71,638,466 +$8,123,297 -$30,810,275 -$22,686,978 OCUL, CDTX, WHWK, SLNO, TRML 13F-HR 14 Aug 2025, 16:50
Q1 2025 33 $86,228,809 +$21,196,096 -$22,394,103 -$1,198,007 OCUL, INSM, TRML, WHWK, ELVN 13F-HR 15 May 2025, 06:33
Q4 2024 39 $99,403,764 +$15,962,212 -$31,533,382 -$15,571,170 OCUL, INSM, TRML, CRNX, ELVN 13F-HR 14 Feb 2025, 07:05
Q3 2024 41 $123,463,831 +$31,090,400 -$45,501,795 -$14,411,395 PCVX, OCUL, TRML, INSM, ELVN 13F-HR 14 Nov 2024, 07:06
Q2 2024 32 $118,636,478 +$19,115,318 -$39,582,265 -$20,466,947 OCUL, ELVN, PCVX, DYN, PRAX 13F-HR 14 Aug 2024, 09:16
Q1 2024 33 $153,941,445 +$30,200,665 -$93,694,806 -$63,494,141 OCUL, PRAX, MRSN, TSHA, RCKT 13F-HR 15 May 2024, 07:56
Q4 2023 38 $177,629,622 +$56,683,546 -$50,750,854 +$5,932,692 RYZB, CBAY, RCKT, KURA, EYPT 13F-HR 14 Feb 2024, 10:29
Q3 2023 51 $138,343,337 +$42,929,307 -$27,896,019 +$15,033,288 TSHA, APLS, AADI, PRAX, RYZB 13F-HR 14 Nov 2023, 09:16
Q2 2023 48 $147,604,554 +$39,337,744 -$40,924,338 -$1,586,594 APLS, AADI, TERN, KURA, SNDX 13F-HR 14 Aug 2023, 08:49
Q1 2023 34 $135,730,826 +$19,619,089 -$27,620,685 -$8,001,596 APLS, AADI, TERN, CBAY, VTYX 13F-HR 15 May 2023, 07:26
Q4 2022 32 $154,929,819 +$42,595,173 -$37,896,853 +$4,698,320 AADI, VRDN, APLS, TERN, UTHR 13F-HR 14 Feb 2023, 15:08
Q3 2022 46 $231,074,000 +$55,599,148 -$4,390,916 +$51,208,232 APLS, AADI, BLU, RLMD, ISEE 13F-HR 14 Nov 2022, 09:24
Q2 2022 41 $177,390,000 +$29,486,846 -$8,715,775 +$20,771,071 APLS, AADI, VTGN, KURA, BLSA 13F-HR 15 Aug 2022, 18:10
Q1 2022 40 $213,959,000 +$38,777,384 -$11,684,166 +$27,093,218 APLS, AADI, VTGN, CLDX, RLMD 13F-HR 16 May 2022, 08:37
Q4 2021 35 $237,734,000 +$64,199,781 -$40,155,157 +$24,044,624 AADI, APLS, VTGN, CLDX, GHRS 13F-HR 14 Feb 2022, 07:12
Q3 2021 46 $280,970,000 +$100,247,168 -$79,444,098 +$20,803,070 AADI, VTGN, ISEE, CLDX, BLU 13F-HR 15 Nov 2021, 14:24
Q2 2021 37 $233,521,000 +$29,674,072 -$85,553,078 -$55,879,006 VTGN, CLDX, APLS, ARWR, BLSA 13F-HR 16 Aug 2021, 12:05
Q1 2021 46 $277,340,000 +$82,414,338 -$138,897,102 -$56,482,764 VTGN, CLDX, KURA, AVDLXXXX, ISEE 13F-HR 17 May 2021, 11:27
Q4 2020 51 $367,181,299 +$97,239,186 -$50,813,684 +$46,425,502 CLDX, SAGE, KURA, LRMR, MRSN 13F-HR 16 Feb 2021, 05:04
Q3 2020 43 $368,224,000 +$157,441,323 -$39,597,787 +$117,843,536 IMMU, KURA, XBI, CLDX, SAGE 13F-HR 16 Nov 2020, 11:17
Q2 2020 46 $346,112,000 +$150,669,053 -$54,556,335 +$96,112,718 ADVM, IMMU, BTAI, IOVA, MRSN 13F-HR 14 Aug 2020, 16:22
Q1 2020 32 $206,318,000 +$61,827,674 -$76,829,371 -$15,001,697 AVDL, AXSM, ADVM, IOVA, ARVN 13F-HR 15 May 2020, 16:11
Q4 2019 38 $403,795,000 +$189,711,582 -$14,951,050 +$174,760,532 AXSM, XBI, ARWR, KDMN, AUPH 13F-HR 14 Feb 2020, 09:50
Q3 2019 31 $138,544,000 +$24,863,569 -$70,826,323 -$45,962,754 KDMN, IOVA, ARVN, XBI, ARWR 13F-HR 13 Nov 2019, 20:15
Q2 2019 30 $281,229,000 +$101,710,139 -$24,680,411 +$77,029,728 IOVA, XBI, KDMN, ADVM, VCYT 13F-HR 14 Aug 2019, 15:36
Q1 2019 32 $197,519,000 +$75,088,659 -$11,618,515 +$63,470,144 IOVA, KDMN, ASMB, INSM, BHVNXXXX 13F-HR 13 May 2019, 21:46
Q4 2018 21 $131,116,000 +$22,601,014 -$54,514,408 -$31,913,394 IOVA, ASMB, KDMN, CASM, XBI 13F-HR 14 Feb 2019, 09:22
Q3 2018 31 $280,350,000 +$6,364,257 -$167,555,175 -$161,190,918 IMMU, ASMB, IOVA, KDMN, CEMI 13F-HR 06 Nov 2018, 20:11
Q2 2018 57 $545,690,000 +$122,750,025 -$108,677,483 +$14,072,542 IMMU, IOVA, ASMB, ARGX, KDMN 13F-HR 14 Aug 2018, 21:12
Q1 2018 58 $605,696,000 +$146,415,559 -$27,757,925 +$118,657,634 IMMU, IOVA, ASMB, XBI, ASND 13F-HR 15 May 2018, 06:13
Q4 2017 74 $529,669,000 +$94,898,213 -$69,496,712 +$25,401,501 IMMU, ASMB, IWM, IOVA, XBI 13F-HR 13 Feb 2018, 20:24
Q3 2017 64 $558,011,000 +$237,914,468 -$32,838,365 +$205,076,103 IMMU, IWM, XBI, ASMB, VCYT 13F-HR 14 Nov 2017, 15:40
Q2 2017 59 $357,080,000 +$115,672,935 -$66,096,526 +$49,576,409 IWM, XBI, ASND, VCYT, IOVA 13F-HR 11 Aug 2017, 18:07
Q1 2017 67 $421,815,000 +$206,131,283 -$59,814,927 +$146,316,356 XBI, IWM, VCYT, ASMB, LBIO 13F-HR 15 May 2017, 06:20
Q4 2016 50 $268,917,000 +$83,173,528 -$17,534,687 +$65,638,841 VCYT, LBIO, IRIX, IMMU, EDGE 13F-HR 13 Feb 2017, 15:26
Q3 2016 66 $264,654,000 +$81,252,971 -$26,177,912 +$55,075,059 LBIO, VCYT, IRIX, IMMU, EVDY 13F-HR 15 Nov 2016, 05:04
Q2 2016 65 $208,097,000 +$73,134,063 -$29,143,310 +$43,990,753 LBIO, VCYT, IRIX, IMMU, RRM 13F-HR 15 Aug 2016, 14:09
Q1 2016 39 $178,587,000 +$70,567,596 -$18,332,607 +$52,234,989 FOLD, VCYT, IMMU, LBIO, ASND 13F-HR 13 May 2016, 17:05
Q4 2015 53 $209,065,000 +$101,726,037 -$11,631,959 +$90,094,078 OLED, LBIO, FOLD, VCYT, IMMU 13F-HR 12 Feb 2016, 15:53
Q3 2015 59 $172,735,000 +$73,120,620 -$17,692,721 +$55,427,899 FOLD, EXEL, ASND, IWM, LBIO 13F-HR 16 Nov 2015, 15:43
Q2 2015 51 $161,746,000 +$81,558,984 -$13,502,602 +$68,056,382 FOLD, AGTC, VCYT, IWM, LBIO 13F-HR 14 Aug 2015, 06:08
Q1 2015 51 $118,727,000 +$51,154,934 -$35,721,569 +$15,433,365 FOLD, LBIO, CEMP, ALIM, BEAT 13F-HR 14 May 2015, 17:49
Q4 2014 63 $147,634,000 $0 IWM, FOLD, QQQXXXX, ALIM, PTX 13F-HR 12 Feb 2015, 16:54